Immunization with megalin induces active Heymann nephritis, which reproduces features of human idiopathic membranous glomerulonephritis. Megalin is a complex immunological target with four discrete ligand-binding domains (LBDs) that may contain epitopes to which pathogenic autoantibodies are directed. Recently, a 236-residue N-terminal fragment, termed "L6," that spans the first LBD was shown to induce autoantibodies and severe disease. We used this model to examine epitope-specific contributions to pathogenesis. Sera obtained from rats 4 weeks after immunization with L6 demonstrated reactivity only with the L6 fragment on Western blot, whereas sera obtained after 8 weeks demonstrated reactivity with all four recombinant fragments of interest (L6 and LBDs II, III, and IV). We demonstrated that the L6 immunogen does not contain the epitopes responsible for the reactivity to the LBD fragments. Therefore, the appearance of antibodies directed at LBD fragments several weeks after the primary immune response suggests intramolecular epitope spreading. In vivo, we observed a temporal association between increased proteinuria and the appearance of antibodies to LBD fragments. These data implicate B cell epitope spreading in antibody-mediated pathogenesis of active Heymann nephritis, a model that should prove valuable for further study of autoimmune dysregulation.
munohistologic and clinical presentation of human membranous glomerulonephritis, including glomerular immune deposits (ID), proteinuria, and nephrotic syndrome. AHN is inducible by immunization with crude renal extracts and more recently with purified rat megalin, the principal target of autoantibodies (autoAb) in glomerular ID. 1 Specific antimegalin responses in AHN and production of passive Heymann nephritis (PHN) with monospecific antimegalin antisera support a role for autoAb in disease progression 2, 3 ; however cell-mediated immunity has also been implicated in the pathogenesis. 4 -6 The autoantigen in the common variety of idiopathic human membranous glomerulonephritis is unknown, although in a few neonatal cases, the neutral endopeptidase on podocytes was identified as the target antigen of maternal alloantibodies. 7 Megalin presents a complex immunologic target, presenting epitopes involved in propagating autoimmunity as well as those involved in deposition of autoAb. A structural organization consisting of four discrete ligand-binding domains (LBD I through IV) is critical to its function as an endocytic receptor. 8 -10 Previous studies 11, 12 assigned significance to specific epitopes within these LBD, which could be targets for "pathogenic" autoAb. Efforts to induce AHN with a fusion protein containing a short sequence of LBD II produced glomerular ID but no evidence of nephrotic disease or proteinuria. 13 Domain-specific rabbit antisera generated against recombinant polypeptides representing LBD I through IV produced glomerular ID in PHN without induction of proteinuria or other clinical consequences. 14 More recently, N-terminal fragments spanning LBD I produced either by proteolysis of native megalin 15 or by expression in baculovirus-insect cells 16 were shown to be as effective as native megalin for inducing AHN. A fragment including residues 1 to 236 induced autoAb and full-blown disease characterized by glomerular ID and severe proteinuria. 17 This study used this model to examine the role of epitope-specific responses in pathogenesis. Immune responses confined to a small fragment would implicate specific determinants in the molecule that mediate disease. Alternatively, further diversification of the immune response by epitope spreading might be required for pathogenesis.
B cell epitope spreading has been described in systemic 18 -20 and organ-specific [21] [22] [23] autoimmune disease models as well as in human disease. 24 -26 Recently, autoAb suggesting intra-and intermolecular epitope spreading were observed in experimental autoimmune glomerulonephritis (EAG) induced with a peptide of the ␣3 chain of type IV collagen 22, 27 ; however, the significance for disease is unclear because this model can also develop without detectable glomerular ID. 28, 29 Deposition of high-affinity autoAb to megalin is the hallmark of AHN. Spreading could therefore reveal the contribution of diversified autoAb to disease progression. For this purpose, recombinant polypeptides representing LBD of megalin were used as antigens to probe specificities of autoAb induced with N-terminal fragments of varying nephritogenicity.
RESULTS

Production and Characterization of Megalin Fragments LBD II, III, and IV
Recombinant polypeptides representing epitopes of three cysteine-rich LBD of rat megalin approximated those previously prepared and used to generate domain-specific antisera. 14 DNA fragments encoding LBD II, III, and IV were obtained by PCR amplification, and each fragment was cloned in the pFASTBac bacmid vector for integration in baculovirus constructs. High-Five insect cells infected with the recombinant baculoviruses were shown to express fragments of the correct size as determined by Western blot with anti-6xHis mAb (Figure 1A) . Purification by affinity chromatography on Ni-NTA resin in the presence of 5 mM mercaptoethanol improved binding and recovery of the proteins, suggesting that inappropriate disulfide cross-linkage inhibited binding to the 6xHis tag. Identities of the polypeptides were confirmed by mass spectrometry/mass spectrometry (MS/MS) analysis of tryptic fragments eluted from in-gel digests of samples resolved by SDS-PAGE. Immunoblot analysis with rat antimegalin antiserum collected at 12 wk from rats with AHN specifically stained all three proteins corresponding to those identified by anti-tag blot ( Figure 1B) . By ELISA, this antiserum had approximately three-fold greater reactivity against the N-terminal and C-terminal fragments as compared with the two internal fragments ( Figure 1C) .
B Cell Epitope Spreading in Anti-L6 Antisera
Sera from Lewis rats immunized with L6 obtained as described previously 17 were diluted 1:5000 for immunoblot of membranes loaded with L6, LBD II, LBD III, and LBD IV. The 4-wk antiserum stained L6 but not the LBD fragments; however, antisera collected at 8 and 12 wk after immunization reacted with all four fragments (Figure 2A ). In two subsequent experiments, groups of six rats were immunized with L6, as before, and sera were collected at 3, 6, and 9 wk. Three-week antisera from all rats in both groups reacted only with L6 as described previously. Six-week sera in one group reacted weakly with all fragments, whereas those of the second group showed only trace or no reaction. The 9-wk sera of all rats in both groups stained all four fragments. and resolved by SDS-PAGE under reducing conditions, and proteins were transferred to polyvinylidene difluoride. Membranes were stained with anti-His6-HRP mAb at a dilution of 1:10,000 (A) or with rat antimegalin antiserum diluted at 1:5000 followed by goat anti-rat IgG-HRP at 1:10,000 dilution (B). (C) Titers of 12-wk antisera collected from rats that had AHN and were immunized with rat megalin determined against the four recombinant fragments adsorbed on microtiter plates.
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Immunoblots were performed as described using 1:5000 diluted 12-wk antisera in the presence of soluble L6 or megalin from Lewis rat kidney. Staining of L6 on the membrane was completely inhibited by L6, whereas staining of LBD fragments was unaffected. By contrast, staining of all antigens was blocked in the presence of megalin ( Figure 2B ).
Proliferation of Lymph Node Cells from Rats with AHN
Lymph nodes of L6-immunized rats collected at 12 wk were used to prepare lymph node cells (LNC) for in vitro proliferation assay. Cells were incubated in the presence of approximately equal amounts, by weight, of L6 or LBD II, III, or IV. Proliferation was strongly stimulated in the presence of Con A, and L6 and LBD IV also induced comparable proliferation; cells incubated in the presence LBD II or III showed only minimal levels of proliferation ( Figure 3 ).
Correlation of Epitope Spreading with Disease
Onset of proteinuria in rats immunized with L6 was seen at 6 to 8 wk with further acceleration at 10 to 12 wk ( Figure 4A ). ELISA of antisera indicated peak titers against L6 at 4 to 6 wk, whereas reactivity to LBD II through IV arose after 6 wk and had maximal values at 9 wk. Thus, linear induction of proteinuria correlated with serum reactivity against LBD fragments, indicative of epitope spreading. By contrast, correlation with anti-L6 reactivity was not significant ( Figure 4B ). AutoAb eluted from kidneys collected at 12 wk had uniformly high reactivity against LBD fragments and L6 ( Figure 5B ).
As reported elsewhere, rats immunized with the smaller Nterminal fragment L3 (residues 1 to 120) also induced hightiter antimegalin autoAb yet developed only mild disease as judged by proteinuria and glomerular complement staining. 17 The 12-wk antisera stained all LBD fragments in Western blot (data not shown); however, ELISA titers determined against L6 and LBD fragments were approximately 60 to 80% and 10 to 20%, respectively, of the anti-L6 antisera titers ( Figure 5A ).
Specificities of autoAb eluted from kidneys of L6-and L3-immunized rats were similarly compared. Eluates from L6-immunized rats at 1:10 dilution bound megalin and LBD II, LBD III, and LBD IV with comparable reactivity. The dominant isotypes included IgG1 and IgG2a, corroborating observations on renal sections 17 (data not shown). Binding of eluates from L3-immunized rats to L6 and LBD fragments was undetectable at 1:10 dilution. Reaction of undiluted eluates was three-fold weaker than 10-fold-diluted L6 eluates ( Figure  5B ).
DISCUSSION
Disease induced with N-terminal megalin fragments was accompanied by antimegalin autoAb in sera and in glomerular ID. 16, 17 In competition ELISA of antisera induced with a 563-residue fragment, the immunogen did not completely inhibit binding to whole megalin, suggesting that autoAb could react at megalin epitopes outside the N-terminal region. 16 In this report, such Ab were observed directly in anti-L6 antisera binding to recombinant fragments LBD II, III, and IV. Two lines of evidence suggested that these autoAb emerge by intramolecular epitope spreading: (1) Reactivity to LBD fragments was delayed by 3 to 4 wk from the primary immune response detected against L6, and (2) soluble L6 failed to inhibit the reaction with LBD fragments on Western blot, whereas native megalin blocked all binding. An immune response to the Hisx6 tag present on each fragment cannot account for cross-reactivity because soluble L6 could be expected to block this binding whereas megalin should not. Immunoblots prepared under reducing SDS-PAGE conditions presum- ably reveal binding to linear epitopes. Although recombinant proteins were poorly resolved under nonreducing conditions, possibly as a result of intermolecular disulfide linkage, binding to nondenatured LBD antigens could be assessed by ELISA. Thus, comparable titers and relative reactivity of antimegalin and anti-L6 sera determined on these fragments suggested that epitope spreading could lead to relevant autoAb, including those specific for conformational epitopes revealed by ELISA. The concurrent appearance of autoAb reacting with all three LBD fragments indicated that diversification did not require sequential B cell epitope spreading. By contrast, T cell epitope spreading seemed restricted to sequences of LBD IV; however, observation at the single 12-wk time point cannot rule out possible hierarchical spreading to other T cell epitopes, typical of relapsing-remitting autoimmunity. Similarly, the role of the N-terminal fragment or cryptic T cell epitopes of LBD IV in breakdown of tolerance remains to be clarified. Preferential binding to L6 and LBD IV by antisera elicited to whole megalin or to L6 could indicate the presence of immunodominant epitopes linked to proximal T cell epitopes present in these fragments.
Two observations supported a role for epitope spreading in pathogenesis. First, the onset of proteinuria correlated with Ab reactivity to LBD fragments rather than with Ab induced to L6. Second, although epitope spreading was seen in both L6-and L3-immunized rats by Western blot, the anti-LBD serum titers were an order of magnitude weaker in L3-immunized rats, which developed only low proteinuria. Similarly, autoAb eluted from kidneys of L6-immunized rats had more pronounced reactivity to LBD fragments than those of the L3-immunized group. Eluates collected at the 12-wk time point exhibited a narrow range of ELISA reactivity, precluding any meaningful correlation with proteinuria variations within either of these groups.
The potential for IgG deposition to impair glomerular filtration leading to proteinuria is associated with both the size of subepithelial ID and the specificity of autoAb for the membrane-anchored antigen. 30 In this context, epitope spreading could enhance polyvalent cross-linkage, forming more stable deposits than those produced by autoAb restricted to epitopes within a small region. This reinforces observations in PHN demonstrating that polyvalent antimegalin Ab induced elec- BASIC RESEARCH www.jasn.org tron-dense subepithelial deposits. 31 By contrast, monovalent antimegalin mAb localized only transiently on podocytes without forming ID. [31] [32] [33] Multivalent cross-linkage could also enhance complement fixation in the immune complex.
B cell epitope spreading has been implicated in several models of Ab-mediated autoimmune disease. 21, 34, 35 Intramolecular B cell epitope spreading may also present a clinical correlate for pathogenesis in human autoimmune disease. 24, 25, 36 The process may be most relevant to disease when autoAb have a direct role in mediating tissue injury or cytotoxicity, as is the case in AHN; however, it could also have a role in amplifying cellmediated immunity through unique antigen-processing capacity of B lymphocytes. 37, 38 In experimental myasthenia gravis, a 210-residue N-terminal fragment of the acetylcholine receptor induced autoAb against C-terminal epitopes of the acetylcholine receptor, including those contained in the cytoplasmic domain. 39 In EAG induced with a peptide from the amino-terminal region of ␣ 3 (IV)NC1, the appearance of autoAb to the whole protein was attributed to epitope spreading. 22, 27 This study describes a feature of AHN that is shared with other models of organ-specific autoimmune disease. As in experimental myasthenia gravis and EAG, an amino-terminal fragment of the autoantigen can trigger epitope spreading, leading to autoAb and T cells that are capable of tissue-specific pathology. Immune deposition is facilitated by the dense presentation of diverse epitopes on a cell surface macromolecule. Cell-mediated immunity has also been implicated in pathogenesis of AHN. 4 -6 Renal autoimmune diseases may also recapitulate the role of T cells in amplifying B cell epitope spreading. 40 The AHN model described here should prove valuable in further investigations of fundamental mechanisms of autoimmune dysregulation in relation to disease progression.
CONCISE METHODS
Reagents, Proteins, and Rats
Procedures were previously described for preparation of native rat megalin 41, 42 and for production of rat antimegalin antisera. 15 Horseradish peroxidase (HRP)-conjugated goat anti-rat Ab and Con A were obtained from Sigma Chemical Co. (St. Louis, MO). HRP-conjugated anti-Hisx6 mAb was from BD Biosciences (Palo Alto, CA). Protein concentrations were determined by modified Bradford assay (BioRad, Hercules, CA). Female Lewis rats obtained at 6 wk of age from Charles River Laboratories (Wilmington, MA) were cared for and used in accordance with protocols approved by the institutional animal care and use committee.
Cloning and Baculovirus Expression of Megalin Fragments
Production of recombinant L6 (residues 1 to 236) and L3 (residues 1 to 120) was recently reported. 17 
Purification and MS Analysis of Recombinant Proteins
Cells were lysed in 10 mM Tris (pH 7.6) containing 1% Triton X100 containing protease inhibitors and were centrifuged (10,000 rpm, 20 min). Supernatants were reduced with 2-mercaptoethanol (5 mM) and purified on NiNTA resin according to the manufacturer's instructions (EMD Biosciences, San Diego, CA). Protein separated by SDS-PAGE was stain by Coomassie, and gel slices were excised, washed in ammonium bicarbonate buffer, reduced (dithiothreitol) and alkylated (iodoacetamide), then digested with sequencing-grade trypsin (Promega, Madison, WI). Eluted peptides were analyzed by matrix-assisted laser desorption ionization MS/MS on an Applied Biosystems (Foster City, CA) 4700 mass spectrometer operated by the University of California, Davis, proteomics facility.
Induction of AHN and Collection of Sera and Renal Eluates
Rats were immunized by intradermal injection at several dorsal sites with recombinant L6 or L3 as previously reported. 17 Urine was collected at 3-wk intervals from rats housed in metabolic cages with free access to water. Total proteinuria was determined by the sulfosalicylic acid method as described previously. 42 Rats were bled from the tail artery at 3, 6, 9, and 12 wk after immunization. Antisera from previous immunizations were collected at 4, 8, and 12 wk. Eluates were prepared as described previously 43 from two kidneys collected at week 12 and diluted to a standard volume for immunoassay comparison.
ELISA and Immunoblot Analysis
Recombinant proteins resolved by SDS-PAGE were stained with Coomassie blue or transferred to Immobilon-P (Millipore, Billerica, MA) for 3 h, 75 V at 4°C. After blocking in Tris-buffered saline [TBS] and 3% non-fat dry milk (NFM), membranes were incubated with rat antimegalin antisera (1:5000 in TBS, 3% NFM, and 0.05% Tween) for 2 h at 4°C. Blots were washed, incubated with goat anti-rat HRP (Southern Biotechnologies, Birmingham, AL) at 1:10,000 dilution in TBS-Tween, and developed with ECL substrates (Amersham Biosciences, Piscataway, NJ). For tag detection, membranes were blocked as described and incubated with anti-Hisx6 mAb-HRP diluted 1:10,000 in TBS-Tween. ELISA plates were coated with rat megalin (0.1 g/well) or megalin fragment L6, LBD II, LBD III, or LBD IV (0.5 g/well) in TBS (pH 7.6) for 2 h at 23°C and blocked with 3% NFM in PBS. Antisera were serially diluted in PBS-Tween and applied for 1 h at room temperature. Plates were washed three times with the PBSTween, and goat anti-rat HRP (1:10,000 in PBS-Tween) was added for 1 h. Plates were then washed as described and developed with tetramethylbenzidine substrate (Pierce Biotechnology, Rockford, IL). Absorbances at 650 nm were corrected for background, and titers were estimated from the half-maximal values. For time course correlation and intergroup comparisons, absorbances at fixed dilution of serum (1:400) or renal eluates (1:10 or undiluted) were used after correction for background absorbance of normal serum or eluate, respectively.
LNC Proliferation Assay
Lymph nodes (popliteal and axillary) were collected at 12 wk from rats immunized with L6 as described previously. Single-cell suspensions in RPMI-1640 2% normal Lewis rat serum, 50 M 2-mercaptoethanol, 100 U penicillin, and 100 g/ml streptomycin were dispensed at 5 ϫ 10 6 cells/well. Proteins or Con A (5 g/ml) in sterile PBS or PBS alone (background) were added in triplicate wells. After 72 h at 37°C in a CO 2 incubator, cells were pulsed for 18 h with 0.5 Ci/well We thank Romina Sacchi and Nadezda Sinitsyna for excellent technical assistance.
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